Cun Wang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 14

Top Topics

Metastatic Renal Cell Carcinoma

Top Venues

Signal transduction and targeted therapy

Nature reviews. Gastroenterology & hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Linmeng Zhang, Ning Tang, Chen Yang, Haigang Geng, Hualian Hang, Wenxin Qin, Cun Wang
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Linmeng Zhang, Ning Tang, Chen Yang, Haigang Geng, Hualian Hang, Wenxin Qin, Cun Wang
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Juanjuan Feng, Zhongwei Hu, Xinting Xia, Xiaogu Liu, Zhengke Lian, Hui Wang, Liren Wang, Cun Wang, Xueli Zhang, Xiufeng Pang
Feedback activation of EGFR/wild-type RAS signaling axis limits KRAS G12D inhibitor efficacy in KRAS G12D -mutated colorectal cancer. Oncogene (2023)
Linmeng Zhang, Ning Tang, Chen Yang, Haigang Geng, Hualian Hang, Wenxin Qin, Cun Wang
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Linmeng Zhang, Ning Tang, Chen Yang, Haigang Geng, Hualian Hang, Wenxin Qin, Cun Wang
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Linmeng Zhang, Ning Tang, Chen Yang, Haigang Geng, Hualian Hang, Wenxin Qin, Cun Wang
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Linmeng Zhang, Ning Tang, Chen Yang, Haigang Geng, Hualian Hang, Wenxin Qin, Cun Wang
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Chen Yang, Hailin Zhang, Mengnuo Chen, Siying Wang, Ruolan Qian, Linmeng Zhang, Xiaowen Huang, Jun Wang, Zhicheng Liu, Wenxin Qin, Cun Wang, Hualian Hang, Hui Wang
A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer. eLife 11 (2022)
Chen Yang, Hailin Zhang, Linmeng Zhang, Andrew X Zhu, René Bernards, Wenxin Qin, Cun Wang
Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nature reviews. Gastroenterology & hepatology (2022)
Xuhui Ma, Shanshan Wu, Botai Li, Qianqian Zhang, Jianming Zhang, Wenming Liu, He-Xin Yan, René Bernards, Wenxin Qin, Cun Wang
EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma. Cell discovery 8 (1) (2022)
Chen Yang, Junfei Chen, Yan Li, Xiaowen Huang, Zhicheng Liu, Jun Wang, Hua Jiang, Wenxin Qin, Yuanyuan Lv, Hui Wang, Cun Wang
Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screen. Briefings in bioinformatics 22 (4) (2021)
Botai Li, Lili Zhu, Chunlai Lu, Cun Wang, Hui Wang, Haojie Jin, Xuhui Ma, Zhuoan Cheng, Chengtao Yu, Siying Wang, Qiaozhu Zuo, Yangyang Zhou, Jun Wang, Chen Yang, Yuanyuan Lv, Liyan Jiang, Wenxin Qin
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nature communications 12 (1) (2021)
Cun Wang, Ying Cao, Chen Yang, René Bernards, Wenxin Qin
Exploring liver cancer biology through functional genetic screens. Nature reviews. Gastroenterology & hepatology 18 (10) (2021)
Haojie Jin, Yaoping Shi, Yuanyuan Lv, Shengxian Yuan, Christel F A Ramirez, Cor Lieftink, Liqin Wang, Siying Wang, Cun Wang, Matheus Henrique Dias, Fleur Jochems, Yuan Yang, Astrid Bosma, E Marielle Hijmans, Marnix H P de Groot, Serena Vegna, Dan Cui, Yang-Yang Zhou, Jing Ling, Hui Wang, Yuchen Guo, Xingling Zheng, Nikita Isima, Haiqiu Wu, Chong Sun, Roderick L Beijersbergen, Leila Akkari, Wei-Ping Zhou, Bo Zhai, Wenxin Qin, René Bernards
EGFR activation limits the response of liver cancer to lenvatinib. Nature 595 (7869) (2021)